Spotlight

UCL cancer immunotherapy company, Autolus, launches with £30m investment

A new UCL spin-out company – Autolus – is being launched today to develop and commercialise a new generation of engineered T-cell therapies for haematological and solid tumours, with the backing of £30m in investment from healthcare investment company Syncona.

Find out more



follow us on twitter


Entrepreneurship Guest Lecture Series

Publication date: Aug 28, 2012 02:11 PM

Start: Nov 22, 2012 05:15 PM

[image reference is broken]

Alex Macpherson - Managing Director, Octopus Ventures
As head of the Ventures division of Octopus Investments, a firm which manages investments worth over £2 billion, Alex Macpherson has built his professional reputation on identifying, assessing and nurturing talented young businesses.

His team specialise in identifying emerging businesses with the potential for market disruption.